A Case of a Child with Chronic Myeloid Leukemia Presenting with Vision and Hearing Loss

Mariam Ngaeje, Furahini Chinenere, Alex Magessa, J. Makani
{"title":"A Case of a Child with Chronic Myeloid Leukemia Presenting with Vision and Hearing Loss","authors":"Mariam Ngaeje, Furahini Chinenere, Alex Magessa, J. Makani","doi":"10.4172/2155-9864.1000333","DOIUrl":null,"url":null,"abstract":"Chronic myeloid leukemia (CML) is a relatively rare malignancy of cells of the hematopoietic system. Loss of vision and hearing is a very rare presenting manifestation of CML especially at a young age. We are reporting a rare case of CML in 16 years old male presenting with loss of hearing and vision in Muhimbili National Hospital in Tanzania. This case shows how the non-communicable disease can cause morbidity in children in a developing world and the importance of early diagnosis and management of CML in prognosis. In addition the case shows how adequate investigations and documentation is important in follow up of the patient clinical conditions and treatment outcomes. The patient was put on Tabs Alluprinol 300mg once daily for one month and Tabs hydroxyl urea (HU) 3g once daily for one month. 2 weeks later the child was reported to have confusion, being overactive and over talkative for 3 days prior to attending the scheduled hematology clinic. Complete Blood Count showed a marked decrease in White blood cells. With the rapid patient’s clinical deterioration after initiation of HU, indicates that detailed medical investigations is crucial in disease management and the use of Tyrosine Kinase inhibitors should be encouraged as it has shown to be more tolerated and better survival outcomes in treatment of CML.","PeriodicalId":182392,"journal":{"name":"Journal of Blood Disorders and Transfusion","volume":"61 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2016-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Blood Disorders and Transfusion","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2155-9864.1000333","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

Abstract

Chronic myeloid leukemia (CML) is a relatively rare malignancy of cells of the hematopoietic system. Loss of vision and hearing is a very rare presenting manifestation of CML especially at a young age. We are reporting a rare case of CML in 16 years old male presenting with loss of hearing and vision in Muhimbili National Hospital in Tanzania. This case shows how the non-communicable disease can cause morbidity in children in a developing world and the importance of early diagnosis and management of CML in prognosis. In addition the case shows how adequate investigations and documentation is important in follow up of the patient clinical conditions and treatment outcomes. The patient was put on Tabs Alluprinol 300mg once daily for one month and Tabs hydroxyl urea (HU) 3g once daily for one month. 2 weeks later the child was reported to have confusion, being overactive and over talkative for 3 days prior to attending the scheduled hematology clinic. Complete Blood Count showed a marked decrease in White blood cells. With the rapid patient’s clinical deterioration after initiation of HU, indicates that detailed medical investigations is crucial in disease management and the use of Tyrosine Kinase inhibitors should be encouraged as it has shown to be more tolerated and better survival outcomes in treatment of CML.
儿童慢性髓性白血病表现为视力和听力丧失1例
慢性髓性白血病(CML)是一种相对罕见的造血系统细胞恶性肿瘤。视力和听力的丧失是CML非常罕见的表现,尤其是在年轻的时候。我们在坦桑尼亚Muhimbili国家医院报告一例罕见的16岁男性慢性粒细胞白血病,表现为听力和视力丧失。这一病例显示了这种非传染性疾病如何在发展中国家的儿童中引起发病率,以及早期诊断和管理慢性粒细胞白血病对预后的重要性。此外,该病例表明,充分的调查和记录对于患者临床状况和治疗结果的随访是多么重要。患者给予阿普利醇300mg片,每日1次,连用1个月;羟脲(HU) 3g片,每日1次,连用1个月。2周后,在参加血液学门诊前3天,患儿报告出现精神错乱、过度活跃和多话。全血细胞计数显示白细胞明显减少。随着HU开始后患者的临床迅速恶化,表明详细的医学调查对疾病管理至关重要,应鼓励使用酪氨酸激酶抑制剂,因为它在治疗CML中具有更强的耐受性和更好的生存结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信